Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang DY, Ye F, Zhao S, Johnson DB. Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: a systematic review and meta-analysis. OncoImmunology. 2017;6(10):e1344805.
Som A, Mandaliya R, Alsaadi D, Farshidpour M, Charabaty A, Malhotra N, Mattar MC. Immune checkpoint inhibitor-induced colitis: a comprehensive review. World J Clin Cases. 2019;7(4):405–18.
Tang L, Wang J, Lin N, Zhou Y, He W, Liu J, Ma X. Immune checkpoint inhibitor-associated colitis: from mechanism to management. Front Immunol. 2021;12:800879.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Briggs, P. (2023). Diarrhoea in the Setting of Immune Checkpoint Inhibitor Therapy. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_88
Download citation
DOI: https://doi.org/10.1007/978-981-99-4440-8_88
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-4439-2
Online ISBN: 978-981-99-4440-8
eBook Packages: MedicineMedicine (R0)